ProfileGDS4718 / 225699_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 76% 61% 68% 70% 65% 83% 89% 73% 68% 69% 75% 64% 83% 85% 84% 76% 66% 83% 85% 72% 70% 69% 65% 74% 73% 86% 69% 84% 77% 85% 83% 81% 57% 61% 85% 84% 86% 69% 70% 75% 68% 80% 79% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4052276
GSM549102patient 115, normal, homogenized [OPG study]6.1983261
GSM549104patient 119, normal, homogenized [OPG study]6.7781468
GSM549108patient 138, normal, homogenized [OPG study]6.8472470
GSM549119patient 077, normal, homogenized [OPG study]6.456465
GSM549133patient 032, cancer, homogenized [OPG study]8.3107583
GSM549139patient 042, cancer, homogenized [OPG study]9.0118989
GSM549099patient 107, normal, homogenized [OPG study]7.0874373
GSM549109patient 139, normal, homogenized [OPG study]6.7150768
GSM549110patient 046, normal, homogenized [OPG study]6.7358469
GSM549114patient 063, normal, homogenized [OPG study]7.3535275
GSM549122patient 082, normal, homogenized [OPG study]6.4027364
GSM549134patient 033, cancer, homogenized [OPG study]8.2943783
GSM549136patient 036, cancer, homogenized [OPG study]8.5825285
GSM549140patient 044, cancer, homogenized [OPG study]8.3979684
GSM549111patient 047, normal, homogenized [OPG study]7.5110876
GSM549113patient 057, normal, homogenized [OPG study]6.5472466
GSM549132patient 031, cancer, homogenized [OPG study]8.196283
GSM549137patient 038, cancer, homogenized [OPG study]8.4614585
GSM549142patient 047, cancer, homogenized [OPG study]6.9888272
GSM549100patient 110, normal, homogenized [OPG study]6.8297270
GSM549107patient 135, normal, homogenized [OPG study]6.7462669
GSM549115patient 068, normal, homogenized [OPG study]6.503365
GSM549116patient 072, normal, homogenized [OPG study]7.2464474
GSM549120patient 078, normal, homogenized [OPG study]7.0923573
GSM549131patient 030, cancer, homogenized [OPG study]8.6392686
GSM549118patient 074, normal, homogenized [OPG study]6.8128769
GSM549129patient 027, cancer, homogenized [OPG study]8.2676184
GSM549123patient 088, normal, homogenized [OPG study]7.5018777
GSM549124patient 006, cancer, homogenized [OPG study]8.4015685
GSM549126patient 015, cancer, homogenized [OPG study]8.2077883
GSM549128patient 025, cancer, homogenized [OPG study]8.0404981
GSM549103patient 117, normal, homogenized [OPG study]5.9353457
GSM549117patient 073, normal, homogenized [OPG study]6.1705761
GSM549138patient 041, cancer, homogenized [OPG study]8.495785
GSM549141patient 045, cancer, homogenized [OPG study]8.4655784
GSM549130patient 028, cancer, homogenized [OPG study]8.5652286
GSM549101patient 111, normal, homogenized [OPG study]6.7806669
GSM549105patient 128, normal, homogenized [OPG study]6.8344870
GSM549106patient 134, normal, homogenized [OPG study]7.4990575
GSM549112patient 048, normal, homogenized [OPG study]6.7337268
GSM549125patient 011, cancer, homogenized [OPG study]7.8534580
GSM549127patient 024, cancer, homogenized [OPG study]7.8515979
GSM549135patient 035, cancer, homogenized [OPG study]9.0643789